Open access · CC-BY
via OpenAlex
Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience
Anthony A. Oliva, Lisa McClain‐Moss, Andrea Pena, Amy Drouillard, Joshua M. Hare
Aging Medicine · 2019 · ▲ 23 citations
Abstract
Extraordinary advances in medicine and public health have contributed to increasing life expectancy worldwide. However, health span-"healthy aging"-has paradoxically lagged to parallel this increase. Consequently, aging-associated illnesses, such as Alzheimer's disease and aging frailty, are having a growing impact on patients, their families, and entire health-care systems. Typically, such disorders have been treated as isolated disease entities. However, the inextricable links between aging-associated disorders and the aging process itself have become increasingly recognized, leading to formation of the field of geroscience. The geroscience concept is that treating the aging process itself should lead to treatment and prevention of aging-related disorders. However, the aging process is complex, dictated by highly interrelated pleiotropic processes. As such, therapeutics with pleiotropic mechanisms of action (either alone, or as part of combinatorial strategies) will be required for preventing and treating both aging and related disorders. Mesenchymal stem cells (MSCs) have multiple mechanisms of action that make these highly promising geroscience therapeutic candidates. These cells have a high safety profile for clinical use, are amenable to allogeneic use since tissue-type matching is not required, and can have sustained activity after transplantation. Herein, we review preclinical and clinical data supporting the utility of allogeneic MSCs as a geroscience therapeutic candidate.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/agm2.12079
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
Oliva, A.A., McClain‐Moss, L., Pena, A., Drouillard, A., & Hare, J.M. (2019). Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience. <em>Aging Medicine</em>. https://doi.org/10.1002/agm2.12079
Vancouver
Oliva AA, McClain‐Moss L, Pena A, Drouillard A, Hare JM. Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience. Aging Medicine. 2019. doi:10.1002/agm2.12079.
BibTeX
@article{anthony2019Alloge,
title = {Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience},
author = {Anthony A. Oliva and Lisa McClain‐Moss and Andrea Pena and Amy Drouillard and Joshua M. Hare},
journal = {Aging Medicine},
year = {2019},
doi = {10.1002/agm2.12079},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
World Journal of Experimental Medicine 2024
Open access · CC-BY
Anti-aging based on stem cell therapy: A scoping review
Stem Cells Translational Medicine 2022
Open access · CC-BY
Mesenchymal Stem/Stromal Cell Senescence: Hallmarks, Mechanisms, and Combating Strategies
Astana Medical Journal 2026
Open access · OA
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
Advances in Wound Care 2012
Open access · OA
Mesenchymal Stem Cells Home to Sites of Injury and Inflammation
Seminars in Liver Disease 2017
Open access · OA
Regenerative Medicine and the Biliary Tree
Biomedicines 2021
Open access · CC-BY